High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk

被引:34
作者
Dura, Polat [1 ]
Salomon, Jody [1 ]
Morsche, Rene H. M. Te [1 ]
Roelofs, Hennie M. J. [1 ]
Kristinsson, Jon O. [1 ]
Wobbes, Theo [2 ]
Witteman, Ben J. M. [3 ]
Tan, Adriaan C. I. T. L. [4 ]
Drenth, Joost P. H. [1 ]
Peters, Wilbert H. M. [1 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Dept Gastroenterol, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Surg, NL-6500 HB Nijmegen, Netherlands
[3] Hosp Gelderse Vallei, Dept Gastroenterol, Ede, Netherlands
[4] Canisius Wilhelmina Hosp, Dept Gastroenterol, Nijmegen, Netherlands
关键词
UDP glucuronosyltransferase; genetic polymorphism; detoxification; biotransformation; esophageal adenocarcinoma; esophageal squamous cell carcinoma; HUMAN UDP-GLUCURONOSYLTRANSFERASES; SERUM BILIRUBIN CONCENTRATION; DELETION POLYMORPHISM; GENETIC POLYMORPHISMS; BLADDER-CANCER; ASSOCIATION; GLUCURONIDATION; CARCINOGEN; EXPRESSION; UGT1A1-ASTERISK-28;
D O I
10.3892/ijo.2012.1385
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Esophageal cancer (EC) has a globally increasing incidence with poor curative treatment options and survival rates. Environmental and dietary factors have crucial roles in esophageal carcinogenesis. Polymorphisms in the UGT genes, a superfamily of enzymes essential for the detoxification of carcinogens, may alter enzyme activity and subsequently may play a role in EC etiology. Rather than solely establishing differences in genotype distribution, we investigated whether functional polymorphisms in UGT genes that can predict enzyme activity in vivo, may influence EC risk. A case-control study including 351 Caucasian EC patients and 592 Caucasian controls was conducted and polymorphisms in seven UGT genes were determined, using the polymerase chain reaction. On the basis of allelic in vitro enzyme activity measurements, genotypes were categorized according to their predicted in vivo enzyme activity into high, medium and low categories. Predicted enzyme activity groups were combined and compared between patients and controls. The UGT1A1 and UGT1A8 predicted high enzyme activity genotypes were significantly more (OR=1.62; 95% Cl, 1.02-2.56) and less frequent (OR=0.36; 95% Cl, 0.15-0.84) among patients with esophageal squamous cell carcinoma (ESCC), respectively. High (OR=0.42; 95% Cl, 0.22-0.84) and medium (OR=0.25; 95% Cl. 0.12-0.52) activity UGT2B4 genotypes were significantly less often present in ESCC patients. No association was detected between UGT genotypes and esophageal adenocarcinoma (EAC) risk. Polymorphisms in UGT genes, resulting in altered enzyme activity genotypes, do not seem modifiers of EAC risk. However, the predicted high activity UGT1A1 genotype, associated with low serum levels of the antioxidant bilirubin, was associated with an increased ESCC risk. The UGT1A8 and UGT2B4 genotypes associated with decreased predicted enzyme activities, were significantly associated with an increased risk of ESCC, probably by a decreased detoxification of carcinogens.
引用
收藏
页码:1789 / 1796
页数:8
相关论文
共 50 条
[1]   Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence [J].
Anderson, Lesley A. ;
Johnston, Brian T. ;
Watson, R. G. Peter ;
Murphy, Seamus J. ;
Ferguson, Heather R. ;
Comber, Harry ;
McGuigan, Jim ;
Reynolds, John V. ;
Murray, Liam J. .
CANCER RESEARCH, 2006, 66 (09) :4975-4982
[2]   Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis [J].
Berkhout, M. ;
Roelofs, H. M. J. ;
Morschel, R. H. M. te ;
Dekker, E. ;
van Krieken, J. H. J. M. ;
Nagengast, F. M. ;
Peters, W. H. M. .
BRITISH JOURNAL OF SURGERY, 2008, 95 (04) :499-505
[3]   Functional Significance of UDP-Glucuronosyltransferase Variants in the Metabolism of Active Tamoxifen Metabolites [J].
Blevins-Primeau, Andrea S. ;
Sun, Dongxiao ;
Chen, Gang ;
Sharma, Arun K. ;
Gallagher, Carla J. ;
Amin, Shantu ;
Lazarus, Philip .
CANCER RESEARCH, 2009, 69 (05) :1892-1900
[4]  
Blot WJ, 1999, SEMIN ONCOL, V26, P2
[5]   Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus [J].
Capello, Astrid ;
Moons, Leon M. G. ;
Van de Winkel, Anouk ;
Siersema, Peter D. ;
van Dekken, Herman ;
Kuipers, Ernst J. ;
Kusters, Johannes G. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (06) :1510-1516
[6]   Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma [J].
Chan, AT ;
Tranah, GJ ;
Giovannucci, EL ;
Hunter, DJ ;
Fuchs, CS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) :457-460
[7]   The cyclooxygenases [J].
Chandrasekharan, NV ;
Simmons, DL .
GENOME BIOLOGY, 2004, 5 (09)
[8]  
Cheng ZQ, 1999, DRUG METAB DISPOS, V27, P1165
[9]   THE RELATION OF GASTROESOPHAGEAL REFLUX DISEASE AND ITS TREATMENT TO ADENOCARCINOMAS OF THE ESOPHAGUS AND GASTRIC CARDIA [J].
CHOW, WH ;
FINKLE, WD ;
MCLAUGHLIN, JK ;
FRANKL, H ;
ZIEL, HK ;
FRAUMENI, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (06) :474-477
[10]   Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications [J].
Ciotti, M ;
Marrone, A ;
Potter, C ;
Owens, IS .
PHARMACOGENETICS, 1997, 7 (06) :485-495